
浏览全部资源
扫码关注微信
1.上海中医药大学附属龙华医院(上海 200032)
2.上海中医药大学脾胃病研究所(上海 200032)
朱浩澜,女,硕士研究生,主要从事中医药防治消化系统肿瘤的基础研究工作
徐汉辰,研究员,博士研究生导师; E-mail:hanson0702@126.com
收稿日期:2024-07-29,
纸质出版日期:2025-09-10
移动端阅览
朱浩澜,刘宇婧,季光,等.基于肠道菌群的中药复方与单体在结直肠癌防治中的研究进展[J].上海中医药杂志,2025,59(9):85-90.
ZHU Haolan,LIU Yujing,JI Guang,et al.Research progress on Chinese medicinal formulas and monomers targeting gut microbiota in prevention and treatment of colorectal cancer[J].Shanghai Journal of Traditional Chinese Medicine,2025,59(9):85-90.
朱浩澜,刘宇婧,季光,等.基于肠道菌群的中药复方与单体在结直肠癌防治中的研究进展[J].上海中医药杂志,2025,59(9):85-90. DOI: 10.16305/j.1007-1334.2025.z20240729001.
ZHU Haolan,LIU Yujing,JI Guang,et al.Research progress on Chinese medicinal formulas and monomers targeting gut microbiota in prevention and treatment of colorectal cancer[J].Shanghai Journal of Traditional Chinese Medicine,2025,59(9):85-90. DOI: 10.16305/j.1007-1334.2025.z20240729001.
肠道菌群失衡与结直肠癌的发生、发展密切相关。基于肠道菌群综述中药复方与单体在结直肠癌防治中的研究进展。中药可通过调控菌群稳态、重塑免疫微环境、调节代谢通路等途径干预结直肠癌进程,肠道菌群是其关键作用靶点。中药复方的多成分可以实现更为全面的肠道菌群调节效果,中药单体则具有明确的作用机制和相对简单的影响路径。深入挖掘中药复方与单体的协同作用模式,可为中医药对结直肠癌的微生态干预提供理论依据和实践指导,推动中医药在结直肠癌防治中的临床转化应用。
Dysbiosis of the gut microbiota is closely associated with the development and progression of colorectal cancer (CRC). This review summarizes research progress on Chinese medicinal formulas and active monomers in the prevention and treatment of CRC. Chinese materia medica may intervene in CRC progression through multiple mechanisms, including the regulation of microbial homeostasis, remodeling of the immune microenvironment, and modulation of metabolic pathways. The gut microbiota serves as a key therapeutic target. The multi-component nature of Chinese medicinal formulas enables a more comprehensive modulation of the gut microbiota, while monomers have clear mechanisms of action and relatively specific pathways. In-depth investigation into the synergistic interactions between Chinese medicinal formulas and monomers may provide both theoretical support and practical guidance for microbiota-targeted interventions in colorectal cancer, thereby promoting the clinical application of TCM in the prevention and treatment of CRC.
ZHANG J G , LIU Y , CHEN Q , et al . Incidence and mortality of colorectal cancer in 2017 and the time-trend from 2010 to 2017 in Henan province,China:a population-based registry study [J]. Ann Transl Med , 2022 , 10 ( 16 ): 878 .
LI N , LU B , LUO C , et al . Incidence, mortality, survival, risk factor and screening of colorectal cancer: A comparison among China,Europe, and northern America [J]. Cancer Lett , 2021 , 522 : 255 - 268 .
DEKKER E , TANIS P J , VLEUGELS J L , et al . Colorectal cancer [J]. Lancet , 2019 , 394 ( 10207 ): 1467 - 1480 .
GILL S R , POP M , DEBOY R T , et al . Metagenomic analysis of the human distal gut microbiome [J]. Science , 2006 , 312 ( 5778 ): 1355 - 1359 .
MISHRA Y , RANJAN A , MISHRA V , et al . The role of the gut microbiome in gastrointestinal cancers [J]. Cell Signal , 2024 , 115 : 111013 .
李扬 . 葛根芩连汤对结直肠癌患者肠道菌群及肠黏膜屏障功能的影响 [D]. 唐山 : 华北理工大学 , 2020 .
GOU H , SU H , LIU D , et al . Traditional medicine Pien Tze Huang suppresses colorectal tumorigenesis through restoring gut microbiota and metabolites [J]. Gastroenterology , 2023 , 165 ( 6 ): 1404 - 1419 .
LIU T , YOU J , GAO Q , et al . The Efficacy and mechanism of Qinghua Jianpi Recipe in inhibiting canceration of colorectal adenoma based on inflammatory cancer transformation [J]. J Immunol Res , 2023 , 2023 : 4319551 .
杨娅楠 , 张芳 , 吴崇明 . 来源于五加科中药通过调节肠道菌群发挥药理作用的研究进展 [J]. 中草药 , 2022 , 53 ( 1 ): 308 - 316 .
SHUWEN H , XI Y , YUEFEN P , et al . Effects of postoperative adjuvant chemotherapy and palliative chemotherapy on the gut microbiome in colorectal cancer [J]. Microb Pathog , 2020 , 149 : 104343 .
章宸浩 , 祝可昕 , 张明洁 , 等 . 中药调控结直肠癌肿瘤微环境的研究进展 [J]. 上海中医药杂志 , 2024 , 58 ( 12 ): 179 - 183 .
XU H , VAN DER JEUGHT K , ZHOU Z , et al . Atractylenolide I enhances responsiveness to immune checkpoint blockade therapy by activating tumor antigen presentation [J]. J Clin Invest , 2021 , 131 ( 10 ): e146832 .
YADAV D , SAINATHAM C , FILIPPOV E , et al . Gut microbiome-colorectal cancer relationship [J]. Microorganisms , 2024 , 12 ( 3 ): 484 .
BOLEIJ A , HECHENBLEIKNER E M , GOODWIN A C , et al . The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients [J]. Clin Infect Dis , 2015 , 60 ( 2 ): 208 - 215 .
TREMBLAY W , MOMPART F , LOPEZ E , et al . Cytolethal distending toxin promotes replicative stress leading to genetic instability transmitted to daughter cells [J]. Front Cell Dev Biol , 2021 , 9 : 656795 .
PLEGUEZUELOS-MANZANO C , PUSCHHOF J , ROSENDAHL HUBER A , et al . Mutational signature in colorectal cancer caused by genotoxic pks + E.coli [J]. Nature , 2020 , 580 ( 7802 ): 269 - 273 .
HWANG S , LEE C G , JO M , et al . Enterotoxigenic Bacteroides fragilis infection exacerbates tumorigenesis in AOM/DSS mouse model [J]. Int J Med Sci , 2020 , 17 ( 2 ): 145 - 152 .
PURCELL R V , PERMAIN J , KEENAN J I . Enterotoxigenic Bacteroides fragilis activates IL-8 expression through Stat3 in colorectal cancer cells [J]. Gut Pathog , 2022 , 14 ( 1 ): 16 .
GRIVENNIKOV S I , GRETEN F R , KARIN M . Immunity,inflammation, and cancer [J]. Cell , 2010 , 140 ( 6 ): 883 - 899 .
HE Z , GHARAIBEH R Z , NEWSOME R C , et al . Campylobacter jejuni promotes colorectal tumorigenesis through the action of cytolethal distending toxin [J]. Gut , 2019 , 68 ( 2 ): 289 - 300 .
GE Z , FENG Y , GE L , et al . Helicobacter hepaticus cytolethal distending toxin promotes intestinal carcinogenesis in 129Rag2-deficient mice [J]. Cell Microbiol , 2017 , 19 ( 7 ): e12728 .
HUBER A R , PLEGUEZUELOS-MANZANO C , PUSCHHOF J , et al . Improved detection of colibactin-induced mutations by genotoxic E.coli in organoids and colorectal cancer [J]. Cancer Cell , 2024 , 42 ( 3 ): 487 - 496 .
ARTHUR J C . Microbiota and colorectal cancer:colibactin makes its mark [J]. Nat Rev Gastroenterol Hepatol , 2020 , 17 ( 6 ): 317 - 318 .
AL ZEIN M , BOUKHDOUD M , SHAMMAA H , et al . Immunotherapy and immunoevasion of colorectal cancer [J]. Drug Discov Today , 2023 , 28 ( 9 ): 103669 .
YIN K , XIA X , RUI K , et al . Myeloid-derived suppressor cells: a new and pivotal player in colorectal cancer progression [J]. Front Oncol , 2020 , 10 : 610104 .
LIU Z , HUANG Q , LIU G , et al . Presence of FOXP3 + Treg cells is correlated with colorectal cancer progression [J]. Int J Clin Exp Med , 2014 , 7 ( 7 ): 1781 - 1785 .
YU A I , ZHAO L , EATON K A , et al . Gut microbiota modulate CD8⁺ T cell responses to influence colitis-associated tumorigenesis [J]. Cell Rep , 2020 , 31 ( 1 ): 107471 .
CASASANTA M A , YOO C C , UDAYASURYAN B , et al . Fusobacterium nucleatum host-cell binding and invasion induces IL-8 and CXCL1 secretion that drives colorectal cancer cell migration [J]. Sci Signal , 2020 , 13 ( 641 ): eaba9157 .
YIN H , MIAO Z , WANG L , et al . Fusobacterium nucleatum promotes liver metastasis in colorectal cancer by regulating the hepatic immune niche and altering gut microbiota [J]. Aging(Albany NY) , 2022 , 14 ( 4 ): 1941 - 1958 .
GAO Y , ZOU T , XU P , et al . Fusobacterium nucleatum stimulates cell proliferation and promotes PD-L1 expression via IFIT1-related signal in colorectal cancer [J]. Neoplasia , 2023 , 35 : 100850 .
WU J , LI Q , FU X . Fusobacterium nucleatum contributes to the carcinogenesis of colorectal cancer by inducing inflammation and suppressing host immunity [J]. Transl Oncol , 2019 , 12 ( 6 ): 846 - 851 .
CREMONESI E , GOVERNA V , GARZON J F G , et al . Gut microbiota modulate T cell trafficking into human colorectal cancer [J]. Gut , 2018 , 67 ( 11 ): 1984 - 1994 .
DEJEA C M , FATHI P , CRAIG J M , et al . Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria [J]. Science , 2018 , 359 ( 6375 ): 592 - 597 .
RAISCH J , ROLHION N , DUBOIS A , et al . Intracellular colon cancer-associated Escherichia coli promote protumoral activities of human macrophages by inducing sustained COX-2 expression [J]. Lab Invest , 2015 , 95 ( 3 ): 296 - 307 .
WANG X , HUYCKE M M . Extracellular superoxide production by Enterococcus faecalis promotes chromosomal instability in mammalian cells [J]. Gastroenterology , 2007 , 132 ( 2 ): 551 - 561 .
SONNENBURG J L , BÄCKHED F . Diet-microbiota interactions as moderators of human metabolism [J]. Nature , 2016 , 535 ( 7610 ): 56 - 64 .
DEVKOTA S , WANG Y , MUSCH M W , et al . Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in IL-10 -/- mice [J]. Nature , 2012 , 487 ( 7405 ): 104 - 108 .
QUINNR A , MELNIKA V , VRBANACA , et al . Global chemical effects of the microbiome include new bile-acid conjugations [J]. Nature , 2020 , 579 ( 7797 ): 123 - 129 .
NGUYENL H , MAW , WANGD D , et al . Association between sulfur-metabolizing bacterial communities in stool and risk of distal colorectal cancer in men [J]. Gastroenterology , 2020 , 158 ( 5 ): 1313 - 1325 .
CONG J , LIU P , HAN Z , et al . Bile acids modified by the intestinal microbiota promote colorectal cancer growth by suppressing CD8⁺ T cell effector functions [J]. Immunity , 2024 , 57 ( 4 ): 876 - 889 .
HE Q , WU J , KE J , et al . Therapeutic role of ursodeoxycholic acid in colitis-associated cancer via gut microbiota modulation [J]. Mol Ther , 2023 , 31 ( 2 ): 585 - 598 .
LI S , XU Z , GUO J , et al . Farnesoid X receptor activation induces antitumour activity in colorectal cancer by suppressing JAK2/STAT3 signalling via transactivation of SOCS3 gene [J]. J Cell Mol Med , 2020 , 24 ( 24 ): 14549 - 14560 .
NGUYEN T T , LIAN S , UNG T T , et al . Lithocholic acid stimulates IL‑8 expression in human colorectal cancer cells via activation of Erk1/2 MAPK and suppression of STAT3 activity [J]. J Cell Biochem , 2017 , 118 ( 9 ): 2958 - 2967 .
HANAHAN D , WEINBERG R A . Hallmarks of cancer:the next generation [J]. Cell , 2011 , 144 ( 5 ): 646 - 674 .
LIU Q , LI A , TIAN Y , et al . The CXCL8-CXCR1/2 pathways in cancer [J]. Cytokine Growth Factor Rev , 2016 , 31 : 61 - 71 .
ZHANG L , LIU J , DENG M , et al . Enterococcus faecalis promotes the progression of colorectal cancer via its metabolite: biliverdin [J]. J Transl Med , 2023 , 21 ( 1 ): 72 .
LIN T L , LU C C , LAI W F , et al . Role of gut microbiota in identification of novel TCM-derived active metabolites [J]. Protein Cell , 2021 , 12 ( 5 ): 394 - 410 .
ZHOU Y , FENG Y , CEN R , et al . San-Wu-Huang-Qin Decoction attenuates tumorigenesis and mucosal barrier impairment in the AOM/DSS model by targeting gut microbiome [J]. Phytomedicine , 2022 , 98 : 153966 .
WANG Y , SONG Y . Sini decoction ameliorates colorectal cancer and modulates the composition of gut microbiota in mice [J]. Front Pharmacol , 2021 , 12 : 609992 .
JIANG F , LIU M , WANG H , et al . Wu Mei Wan attenuates CAC by regulating gut microbiota and the NF-κB/IL6-STAT3 signaling pathway [J]. Biomed Pharmacother , 2020 , 125 : 109982 .
CAI K , CAO X Y , CHEN F , et al . Xianlian Jiedu Decoction alleviates colorectal cancer by regulating metabolic profiles,intestinal microbiota and metabolites [J]. Phytomedicine , 2024 , 128 : 155385 .
刘瑞芳 . 从胆固醇-胆汁酸代谢异常探讨痰对小鼠结直肠癌发病率的影响研究 [D]. 福州 : 福建中医药大学 , 2021 .
QIU W , SANG T , CHEN H , et al . Wenzi Jiedu Recipe ameliorates colorectal cancer by remodeling the gut microbiota and tumor microenvironment [J]. Front Oncol , 2022 , 12 : 915498 .
SUI H , ZHANG L , GU K , et al . YYFZBJS ameliorates colorectal cancer progression in Apc Min/+ mice by remodeling gut microbiota and inhibiting regulatory T-cell generation [J]. Cell Commun Signal , 2020 , 18 : 1 - 17 .
ZHU J J , LIU H Y , YANG L J , et al . Anti-tumour effect of Huangqin Decoction on colorectal cancer mice through microbial butyrate mediated PI3K/Akt pathway suppression [J]. J Med Microbiol , 2023 , 72 ( 5 ): 001692 .
FENG R , SHOU J W , ZHAO Z X , et al . Transforming berberine into its intestine-absorbable form by the gut microbiota [J]. Sci Rep , 2015 , 5 ( 1 ): 12155 .
CAO F , XIA W , DAI S , et al . Berberine:An inspiring resource for the treatment of colorectal diseases [J]. Biomed Pharmacother , 2023 , 167 : 115571 .
ZHOU Y , LIU Z , CHEN Y , et al . Identification of the protective effects of traditional medicinal plants against SDS-induced Drosophila gut damage [J]. Exp Ther Med , 2016 , 12 ( 4 ): 2671 - 2680 .
王睿 , 王霖 , 魏广义 , 等 . 黄芩素调节肠道菌群并改善小鼠化疗诱导性肠黏膜炎的作用及其机制 [J]. 药学学报 , 2020 , 55 ( 5 ): 868 - 876 .
魏娇 , 征宗梅 , 侯新新 , 等 . 黄芩苷调节肠道菌群抑制高脂饮食诱导的结直肠癌肝转移研究 [J]. 上海中医药杂志 , 2023 , 57 ( 10 ): 59 - 67 .
CAI J , LIU J , FAN P , et al . Dioscin prevents DSS-induced colitis in mice with enhancing intestinal barrier function and reducing colon inflammation [J]. Int Immunopharmacol , 2021 , 99 : 108015 .
KHAN I , HUANG G , LI X A , et al . Mushroom polysaccharides and jiaogulan saponins exert cancer preventive effects by shaping the gut microbiota and microenvironment in Apc Min/+ mice [J]. Pharmacol Res , 2019 , 148 : 104448 .
刘思弟 , 马贲 , 郑言 , 等 . 肠道菌群调控动物肠道黏膜免疫和炎症的研究进展 [J]. 畜牧兽医学报 , 2024 , 55 ( 4 ): 1423 - 1431 .
吕骥 . 葛根芩连汤联合PD-1抑制剂通过重塑免疫微环境治疗结肠癌的机制研究 [D]. 石家庄 : 河北医科大学 , 2020 .
李道明 , 王蓉 , 谢菁 . 黄芪桂枝五物汤治疗奥沙利铂化疗后周围神经毒性24例 [J]. 南京中医药大学学报 , 2014 , 30 ( 2 ): 186 - 188 .
章玲艳 , 吴会晨 , 汪飞 , 等 . 参苓白术散加减对结直肠癌患者化疗后骨髓抑制和免疫功能的影响 [J]. 陕西中医 , 2023 , 44 ( 8 ): 1086 - 1089 .
彭子真 . 醒脾畅胃法对结直肠癌辅助化疗期生活质量影响的临床观察 [D]. 济南 : 山东中医药大学 , 2023 .
李宝乐 , 李小叶 , 任顺平 , 等 . 基于肠道菌群对膈下逐瘀汤治疗毒瘀内结证晚期结直肠癌患者作用机制的研究 [J]. 中国中西医结合消化杂志 , 2023 , 31 ( 12 ): 974 - 979 .
DENG G L , ZHOU L S , WANG B L , et al . Targeting cathepsin B by cycloastragenol enhances antitumor immunity of CD8 T cells via inhibiting MHC-I degradation [J]. J Immunother Cancer , 2022 , 10 ( 10 ): e004874 .
0
浏览量
0
下载量
0
CSCD
0
CNKI被引量
关联资源
相关文章
相关作者
相关机构
沪公网安备 31011502015228号